Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy is a research paper published in Cardiovascular Ultrasound (2022). On theSindex it has a DataRank of 0.717. It has been cited 15 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.302
From 9 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
National Institutes of Health
Grant: R01-HL078610; R01-HL130046
NHLBI NIH HHS
Grant: R01 HL130046
NHLBI NIH HHS
Grant: R01 HL078610
MeSH Terms
Keywords
Additional file 1 of Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
Additional file 1 of Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy